Loading...
•
Sep 30
GoHealth Q3 2025 Earnings Report
GoHealth reported a Q3 net loss of $165.85 million on revenues of $34.19 million amid a strategic pullback in Medicare Advantage volume.
Key Takeaways
GoHealth’s Q3 2025 results reflect an intentional shift away from volume-driven growth to focus on retention, quality, and strategic flexibility. While revenue dropped significantly year-over-year, the company reinforced its core capabilities to align with changing market dynamics.
Net revenue for Q3 2025 declined to $34.19 million from $118.29 million in Q3 2024.
The company posted a net loss of $165.85 million, primarily due to impairment charges and higher G&A expenses.
Submissions dropped 57% YoY to 72,183, reflecting the company’s strategic pullback.
Adjusted EBITDA was $(47.09) million with a margin of -137.7%.
GoHealth
GoHealth
GoHealth Revenue by Segment
Revenue by Segment
Medicare Agency Revenue
CapyFin.comMedicare Non-Agency Revenue
CapyFin.comOther Non-Agency Revenue
CapyFin.comOther Agency Revenue
CapyFin.com Forward Guidance
GoHealth expects continued pressure on top-line growth due to its deliberate pullback, but believes its strategic positioning and retained core capabilities will enable it to capitalize when the market stabilizes.
Positive Outlook
- Preserved liquidity with $32.08M in cash and equivalents.
- Strengthened retention model and platform efficiency.
- Maintained leadership position in Special Needs Plans.
- Improved focus on high-quality member base over raw growth.
- Streamlined cost structure to enhance operational flexibility.
Challenges Ahead
- 71% YoY revenue decline highlights impact of reduced volume.
- Massive impairment charge of $206M affected profitability.
- Submissions fell 57% YoY to 72,183 in Q3 2025.
- Adjusted EBITDA margin deeply negative at -137.7%.
- Sales per submission decreased 34% YoY to $461.